Gempharmatech Co. Ltd. A (688046) — Working Capital to Net Assets Ratio
Gempharmatech Co. Ltd. A (688046) has a Working Capital to Net Assets ratio of 57.1% as of June 2025. Working capital of CN¥1.24 Billion (current assets of CN¥1.78 Billion minus current liabilities of CN¥543.76 Million) is measured against net assets of CN¥2.17 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Gempharmatech Co. Ltd. A balance sheet quality to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Gempharmatech Co. Ltd. A Working Capital to Net Assets (2019–2024)
This chart shows how Gempharmatech Co. Ltd. A's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2019 to 2024. As of June 2025, the ratio stands at 57.1%, reflecting working capital of CN¥1.24 Billion against net assets of CN¥2.17 Billion CNY. Check tangible equity quality of Gempharmatech Co. Ltd. A to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Gempharmatech Co. Ltd. A (2019–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Gempharmatech Co. Ltd. A from 2019 to 2024, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 688046 stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 62.7% | CN¥1.34 Billion | CN¥2.13 Billion | CN¥1.71 Billion | CN¥371.20 Million | ▲ +1.9 pp |
| 2023 | 60.8% | CN¥1.29 Billion | CN¥2.12 Billion | CN¥1.66 Billion | CN¥366.41 Million | ▼ -2.6 pp |
| 2022 | 63.4% | CN¥1.25 Billion | CN¥1.98 Billion | CN¥1.47 Billion | CN¥214.07 Million | ▼ -2.2 pp |
| 2021 | 65.6% | CN¥515.19 Million | CN¥785.63 Million | CN¥706.93 Million | CN¥191.74 Million | ▼ -10.2 pp |
| 2020 | 75.7% | CN¥497.78 Million | CN¥657.24 Million | CN¥647.25 Million | CN¥149.47 Million | ▼ -9.7 pp |
| 2019 | 85.5% | CN¥205.55 Million | CN¥240.47 Million | CN¥329.03 Million | CN¥123.48 Million | — |